Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response

After neoadjuvant chemoradiotherapy for esophageal adenocarcinoma, up to 29% of patients have a pathological complete response (pCR). What to do afterward is still under debate. The aim of this prospective study was to define which local markers of immune response might act as predictors of pCR and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Kotsafti, Andromachi, Scarpa, Melania, Cavallin, Francesco, Fassan, Matteo, Salmaso, Roberta, Porzionato, Andrea, Saadeh, Luca, Cagol, Matteo, Alfieri, Rita, Castoro, Carlo, Rugge, Massimo, Castagliuolo, Ignazio, Scarpa, Marco
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458640/
https://ncbi.nlm.nih.gov/pubmed/32923165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1804169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados